title: Everolimus-induced posterior reversible encephalopathy syndrome and bilateral optic neuropathy after kidney transplantation.
authors.affiliation: 1 Ophthalmology Department DHU View Maintain, Hôpital Pitié Salpêtrière Paris, France 2 Urology, Nephrology and Transplantation Department Hôpital Pitié Salpêtrière Paris, France 3 Internal Medicine Department CHNO des Quinze-vingts, Charenton Paris, France 4 Neuroradiology Department Hôpital Pitié Salpêtrière Paris, France 5 Université Pierre et Marie Curie (UMPC) Faculté de Médecine Paris, France.
authors.forename: Sara
authors.initials: S
authors.lastname: Touhami
authors.forename: Nadia
authors.initials: N
authors.lastname: Arzouk
authors.forename: Adil
authors.initials: A
authors.lastname: Darugar
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Heron
authors.forename: Frederic
authors.initials: F
authors.lastname: Clarençon
authors.forename: Bahram
authors.initials: B
authors.lastname: Bodaghi
authors.forename: Phuc
authors.initials: P
authors.lastname: LeHoang
authors.forename: Benoit
authors.initials: B
authors.lastname: Barrou
authors.forename: Valerie
authors.initials: V
authors.lastname: Touitou
mesh_terms: D000068338:Everolimus; D005260:Female; D005922:Glomerulonephritis, IGA / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D008875:Middle Aged; D009901:Optic Nerve Diseases / Q000139:chemically induced*; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced*; D011183:Postoperative Complications; D020123:Sirolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014785:Vision, Ocular / Q000187:drug effects
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus